论文部分内容阅读
目的块状型肝癌多途径治疗后再二期手术切除２３例疗效分析。方法：我所从１９８３年３月至１９９３年１２月共收治原发块状型肝癌５６例，经肝动脉结扎、碘化油化疗药物（Ｍ、Ｄ、Ｆ）混合液灌注、液态硅胶（ＴＨ）栓塞、肝动脉远心端门静脉保留化疗管，术后分期灌注化疗，化疗期间经皮行癌灶无水酒精注射。结果：一期术后半年定期复查瘤体缩小ＰＲ：６０７％（３４／５６）、ＭＲ：２８５％（１６／５６）、ＳＤ：１０７％（６／５６）。复查后依据各个瘤体缩小及体质实况施行二期手术切除２３例、手术切除率为４１１％（２３／５６）。结论：二期手术病例随访结果：１，３，５年生存率为８２６％（１９／２３）、６８３％（１６／２３）、５２３％（９／１７）。（术后满５年者１７例生存９例）。
Objective Multi-channel treatment of massive liver cancer after secondary resection of 23 cases of efficacy analysis. METHODS: From March 1983 to December 1993, a total of 56 cases of primary massive liver cancer were treated and treated with hepatic artery ligation, iodized oil chemotherapy (M, D, F) mixed liquid, liquid silicone (TH ) Embolization, hepatic artery distal portal vein retention of chemotherapy, postoperative chemotherapy infusion, and percutaneous ethanol injection during chemotherapy. RESULTS: During the first half of the first phase, the tumors were periodically reviewed for PR: 60 7% (34/56), MR: 28 5% (16/56), and SD: 10 7% (6/56). After reexamination, 23 cases underwent secondary surgical resection and the surgical resection rate was 41.1% (23/56). Conclusion: The follow-up results of the second-stage surgical cases: The 1-, 3-, 5-year survival rates were 82.6% (19/23), 68. 3% (16/23), and 52. 3% (9/17). (After 5 years of surgery, 17 cases survived in 9 cases).